Anúncio
Anúncio
SPRB
Spruce Biosciences, Inc. Common Stock
79.99
USDPatrocinado
+5.85
+7.94%
09 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
79.00
-0.99
-1.24%
Relatórios de Lucros SPRB
Rácio de surpresa positiva
SPRB separação 14 de 21 últimas estimativas.
67%
Próximo Relatório
Data do Próximo Relatório
13 de abr. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$8.14
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-44.17%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-100.00%
/-80.96%
Spruce Biosciences, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, SPRB reported earnings of -14.58 USD per share (EPS) for Q3 25, missing the estimate of -14.21 USD, resulting in a -2.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -8.14 USD, with revenue projected to reach -- USD, implying an diminuir of -44.17% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Spruce Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Spruce Biosciences, Inc. Common Stock reported EPS of -$14.58, missing estimates by -2.58%, and revenue of $0.00, 0% as expectations.
How did the market react to Spruce Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.55%, changed from $115.61 before the earnings release to $112.66 the day after.
When is Spruce Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 13 de abr. de 2026.
What are the forecasts for Spruce Biosciences, Inc. Common Stock's next earnings report?
Based on 5
analistas, Spruce Biosciences, Inc. Common Stock is expected to report EPS of -$8.14 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio